AR241703A1 - Procedimiento para la elaboracion de 2(piridil e imidazolil)indoles y sus sales - Google Patents
Procedimiento para la elaboracion de 2(piridil e imidazolil)indoles y sus salesInfo
- Publication number
- AR241703A1 AR241703A1 AR84296691A AR29669184A AR241703A1 AR 241703 A1 AR241703 A1 AR 241703A1 AR 84296691 A AR84296691 A AR 84296691A AR 29669184 A AR29669184 A AR 29669184A AR 241703 A1 AR241703 A1 AR 241703A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- alkenylene
- alkylene
- alcoxy
- compound
- Prior art date
Links
- 150000002475 indoles Chemical class 0.000 title abstract 2
- -1 IMIDAZOLYL Chemical class 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical class [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 1
- 230000009435 amidation Effects 0.000 abstract 1
- 238000007112 amidation reaction Methods 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical class [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/495,367 US4511573A (en) | 1983-05-17 | 1983-05-17 | 3-Substituted-2-(heteroaryl) indoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR241703A1 true AR241703A1 (es) | 1992-11-30 |
Family
ID=23968361
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR84296691A AR241703A1 (es) | 1983-05-17 | 1984-05-17 | Procedimiento para la elaboracion de 2(piridil e imidazolil)indoles y sus sales |
| AR87307164A AR242202A1 (es) | 1983-05-17 | 1987-03-31 | Procedimiento para la elaboracion de 2-(piridil)-indoles |
| AR87307165A AR242204A1 (es) | 1983-05-17 | 1987-03-31 | Procedimiento para la elaboracion de 2-imidazolil-indoles. |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR87307164A AR242202A1 (es) | 1983-05-17 | 1987-03-31 | Procedimiento para la elaboracion de 2-(piridil)-indoles |
| AR87307165A AR242204A1 (es) | 1983-05-17 | 1987-03-31 | Procedimiento para la elaboracion de 2-imidazolil-indoles. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4511573A (en, 2012) |
| EP (1) | EP0129051B1 (en, 2012) |
| JP (1) | JPS59225181A (en, 2012) |
| KR (1) | KR890000521B1 (en, 2012) |
| AR (3) | AR241703A1 (en, 2012) |
| AT (1) | ATE54314T1 (en, 2012) |
| AU (1) | AU560255B2 (en, 2012) |
| CA (1) | CA1255679A (en, 2012) |
| DD (1) | DD223713A5 (en, 2012) |
| DE (1) | DE3482629D1 (en, 2012) |
| DK (1) | DK242584A (en, 2012) |
| ES (3) | ES8702906A1 (en, 2012) |
| FI (1) | FI83218C (en, 2012) |
| GR (1) | GR79935B (en, 2012) |
| HU (1) | HU197565B (en, 2012) |
| IE (1) | IE57446B1 (en, 2012) |
| IL (1) | IL71833A (en, 2012) |
| NO (1) | NO161801C (en, 2012) |
| NZ (1) | NZ208177A (en, 2012) |
| PH (1) | PH22245A (en, 2012) |
| PT (1) | PT78581A (en, 2012) |
| ZA (1) | ZA843679B (en, 2012) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4536505A (en) * | 1983-05-17 | 1985-08-20 | Ciba-Geigy Corporation | Certain N-(pyridyl) indoles |
| US4675332A (en) * | 1984-12-10 | 1987-06-23 | Warner-Lambert Company | Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents |
| US4609733A (en) * | 1984-12-27 | 1986-09-02 | Ciba-Geigy Corporation | 3-keto-substituted-N-pyridylindoles |
| DE3780438T2 (de) * | 1986-11-27 | 1993-01-28 | Beecham Group Plc | N-substituierte cyclische amine, ihre herstellung sowie pharmazeutische zusammensetzungen die sie enthalten. |
| US4962105A (en) | 1987-10-19 | 1990-10-09 | Ciba-Geigy Corporation | Potentiation of antihypertensive effect of ace inhibitors |
| US4996328A (en) * | 1989-03-08 | 1991-02-26 | Appleton Papers Inc. | Bis-(indolyl)ethylenes |
| US6184238B1 (en) | 1996-12-26 | 2001-02-06 | Nikken Chemicals Co., Ltd. | N-hydroxyurea derivative and pharmaceutical composition containing the same |
| AR072297A1 (es) * | 2008-06-27 | 2010-08-18 | Novartis Ag | Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona. |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3468894A (en) * | 1966-11-29 | 1969-09-23 | Geigy Chem Corp | Certain 2-pyridyl-substituted indole derivatives |
| US3557142A (en) * | 1968-02-20 | 1971-01-19 | Sterling Drug Inc | 4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters |
| JPS6050190B2 (ja) * | 1978-05-02 | 1985-11-07 | 小野薬品工業株式会社 | イミダゾ−ル誘導体 |
| GB2016452B (en) * | 1978-02-18 | 1982-07-21 | Kissei Pharmaceutical | Imidazole compounds |
| EP0003901B1 (en) * | 1978-02-24 | 1981-08-05 | Pfizer Limited | 3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them |
| JPS55313A (en) * | 1978-06-13 | 1980-01-05 | Kissei Pharmaceut Co Ltd | Imidazole derivative |
| DK471479A (da) * | 1978-12-13 | 1980-06-14 | Pfizer | Fremgangsmaade til fremstilling af imidazolderivater og salte deraf |
| GB2045244B (en) * | 1979-03-07 | 1983-01-26 | Pfizer Ltd | 3-1-(imidazolylalkyl) indoles |
| DK151884C (da) * | 1979-03-07 | 1988-06-13 | Pfizer | Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf |
| GR75101B (en, 2012) * | 1980-10-23 | 1984-07-13 | Pfizer | |
| US4363912A (en) * | 1980-12-15 | 1982-12-14 | Pfizer Inc. | Indole thromboxane synthetase inhibitors |
| GB2102795A (en) * | 1981-07-31 | 1983-02-09 | Pfizer Ltd | Indole derivatives |
| ZA825413B (en) * | 1981-08-26 | 1983-06-29 | Pfizer | Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them |
| US4460777A (en) * | 1981-11-19 | 1984-07-17 | Ciba-Geigy Corporation | N-Substituted-2-pyridylindoles |
| US4478842A (en) * | 1981-11-19 | 1984-10-23 | Ciba-Geigy Corporation | N-Substituted-2-pyridylindoles |
| GB2111050B (en) * | 1981-11-19 | 1985-09-11 | Ciba Geigy Ag | N-substituted-2-pyridylindoles |
| US4436746A (en) * | 1982-09-30 | 1984-03-13 | Ciba-Geigy Corporation | Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles |
-
1983
- 1983-05-17 US US06/495,367 patent/US4511573A/en not_active Expired - Lifetime
-
1984
- 1984-05-14 FI FI841926A patent/FI83218C/fi not_active IP Right Cessation
- 1984-05-14 DE DE8484105450T patent/DE3482629D1/de not_active Expired - Lifetime
- 1984-05-14 EP EP84105450A patent/EP0129051B1/de not_active Expired - Lifetime
- 1984-05-14 AT AT84105450T patent/ATE54314T1/de not_active IP Right Cessation
- 1984-05-15 CA CA000454326A patent/CA1255679A/en not_active Expired
- 1984-05-15 PT PT78581A patent/PT78581A/pt not_active IP Right Cessation
- 1984-05-15 GR GR74707A patent/GR79935B/el unknown
- 1984-05-15 IL IL71833A patent/IL71833A/xx unknown
- 1984-05-16 PH PH30688A patent/PH22245A/en unknown
- 1984-05-16 DD DD84263082A patent/DD223713A5/de not_active IP Right Cessation
- 1984-05-16 JP JP59096751A patent/JPS59225181A/ja active Granted
- 1984-05-16 DK DK242584A patent/DK242584A/da not_active Application Discontinuation
- 1984-05-16 HU HU841892A patent/HU197565B/hu not_active IP Right Cessation
- 1984-05-16 ZA ZA843679A patent/ZA843679B/xx unknown
- 1984-05-16 NZ NZ208177A patent/NZ208177A/en unknown
- 1984-05-16 NO NO841959A patent/NO161801C/no unknown
- 1984-05-16 IE IE1212/84A patent/IE57446B1/en not_active IP Right Cessation
- 1984-05-16 AU AU28095/84A patent/AU560255B2/en not_active Ceased
- 1984-05-16 KR KR1019840002657A patent/KR890000521B1/ko not_active Expired
- 1984-05-17 ES ES532573A patent/ES8702906A1/es not_active Expired
- 1984-05-17 AR AR84296691A patent/AR241703A1/es active
-
1985
- 1985-07-09 ES ES544998A patent/ES8706629A1/es not_active Expired
- 1985-07-09 ES ES544997A patent/ES8706628A1/es not_active Expired
-
1987
- 1987-03-31 AR AR87307164A patent/AR242202A1/es active
- 1987-03-31 AR AR87307165A patent/AR242204A1/es active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3867074D1 (de) | Elektrochemische sauerstoffentfernung als korrosionsschutz fuer deionisiertes wasser. | |
| CO4520286A1 (es) | Procedimiento para preparar clorhidrato de 1-(2 -desoxi-2 , 2 -difluoro-d-ribofuranosil)-4-aminopirimidin-2-ona | |
| NO884184L (no) | Fremgangsmaate for aa hindre dannelse av gasshydrater i en vaatgass-stroem. | |
| AU4919199A (en) | Electrochemiluminescence cell with floating reaction electrodes | |
| ES2095966T3 (es) | Combustion con chorro coherente. | |
| FR2605039B1 (fr) | Serrure pour vehicules, assistee par une source d'energie. | |
| AR241703A1 (es) | Procedimiento para la elaboracion de 2(piridil e imidazolil)indoles y sus sales | |
| FR2691424B1 (fr) | Propulseur individuel utilisant l'energie electrique en milieu sous-marin. | |
| DE69304641D1 (de) | Solarkollektor | |
| DE50212598D1 (de) | Mobile Vorrichtung zur Energieversorgung mit Brennstoffzellen | |
| NO972229D0 (no) | Flokkuleringsanordning | |
| AR020703A1 (es) | Barra de limpieza de superficies duras. | |
| TW370574B (en) | Hydrogen storage alloy | |
| IT8220915A0 (it) | Procedimento per il posizionamento di una apparecchiatura per laproduzione di idrocarburi estratti dal fondo sottomarino, e apparecchiatura di produzione perl'attuazione del procedimento. | |
| IT8519583A0 (it) | Rubinetto con dispositivo di fermo per il corpo di azionamento,parti colarmente per bombole di gasliquido | |
| IL115122A (en) | Method for the preparation of 3,4-dihydroxy-5-nitrobenzaldehyde | |
| DE3781735D1 (de) | Korrosionsschutz. | |
| SU1540328A1 (ru) | Ингибитор сероводородной коррозии стали | |
| TW336228B (en) | Substituted biphenyloxazolines the invention relates to substituted biphenyloxazolines | |
| DE69715648D1 (de) | Tankbehälter mit alarmanlage | |
| Guirkinger et al. | Drinking water and waste water in Rostock-the transition from a state enterprise to a private service company for the water supply and disposal for the area | |
| ES2175731T3 (es) | Dispositivos para tomar bebidas. | |
| ES1000948U (es) | Un anodo automontable | |
| DE59912855D1 (de) | Vorrichtung zur Bereitstellung einer kryogenen Flüssigkeit | |
| NO924426D0 (no) | Lagringstank for hydrogen |